Zai Lab Limited has grown revenue 21% a year over three years and 39% a year over five. Revenue growth, 3-year annual rate: +21% (Biotechnology median +17%). Revenue growth, 5-year rate: +39%, growth has slowed since the five-year average. Years of annual history on file: 11, FY2015 to FY2025, as filed.

ZLABZai Lab Limited

Healthcare

$25.01-23% 1Y

$25.01

$16.3052 weeks$34.44

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−1.7 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+5% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +39% a year.

Margin direction−1.7 points operating

Trailing-twelve-month operating margin, -59.5% now against -57.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ZLAB growing?

Zai Lab Limited has grown revenue 21% a year over three years and 39% a year over five.

+21%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +39%
Revenue growth, 5-year rate · +21% over three · growth has slowed since the five-year average
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›